Regulated investment firm, Koodos, has accelerated the growth of its existing investments by an impressive 140% over the last 12 months following the success of its purpose-driven strategy.
Established in 2023, Koodos provides structured access to venture opportunities with FCA-regulated oversight, modern technology and a founder-first approach.
Driven by co-founders, Nat Hutley, Ian Hubert and Peter Ward – the founding partner of investment firm, Rcapital – Koodos has since set itself aside from industry competitors with a human approach to investment, with a clear focus in the healthcare, life sciences, and oncology sectors.
As such, Koodos has raised over £30 million via 350+ investors over the last 18 months alone, while backing the growth and development of multiple pioneering biotech businesses, already on track to revolutionise cancer treatment worldwide.
Nat Hutley, co-founder and CEO of Koodos, confirmed: “At Koodos, we’re building something fundamentally different. Our focus is on backing companies that genuinely improve people’s lives, while helping investors access opportunities they wouldn’t normally see.
We believe investment should go beyond returns alone and should create meaningful, real-world impact. That’s why we’re particularly focused on areas like healthcare, where innovation has the potential to transform people’s lives at scale.
The momentum we’re seeing reflects a growing demand from investors who want both strong financial performance and a clear sense of purpose — and we’re proud to be at the forefront of that movement.”
Headquartered in Mayfair, Koodos is an Appointed Representative of Sapeno Partners LLP, which is authorised and regulated by the Financial Conduct Authority (FCA).
For more information, visit: https://koodos-group.com
Leave a Comment